Genedata introduces AI analytics to enhance quality control and novel phenotype detection in high-content screening
New release of Genedata Imagence boosts speed, efficiency, and quality of HCS image analysis
New release of Genedata Imagence boosts speed, efficiency, and quality of HCS image analysis
Thermo Fisher Scientific–Genedata collaboration aims to accelerate the discovery and development of next-generation biotherapeutics
Innovative software solution enables efficient analysis of phenotypic high-content screens
Leading platform for screening data analysis delivers new capabilities for real-time analysis and direct data imports to a research data warehouse
New partners join the turnkey integration program with Genedata Screener enabling researchers to quickly import and analyze raw data from innovative screening instruments
Extending its Genedata Screener licensing, ONO accelerates drug discovery with Screener's streamlined workflows and high speed data analysis
Genedata Screener with New SPR, DMPK, HT-Flow and HT-Electrophysiology Support Showcases at SLAS2016
New five-year license agreement extends AstraZeneca-Genedata partnership; Genedata Screener now AstraZeneca’s corporate platform for expediting drug discovery
Used by the world's leading research organizations, Screener for HCS is the most effective, streamlined decision-making platform for image-based screening.
Developed through industry partnerships, the leading platform for all in-vitro screening again raises the bar on efficiency, versatility, and consistency.
Ready-to-Run: Time-savings - Improved User Workflows - Better Science